Anuj Chandra, MD
Sleep Medicine · Trenton, GANPI 1710977301
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (42.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Harmony Biosciences LLC at 59.0% of the total. Reporting peaked in 2023 at $11,878 and has fallen 93.5% since, to $775 in 2025. Among sleep medicine clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 244 payments — averaging $81.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Harmony Biosciences LLC$12K
- Inspire Medical Systems, Inc.$4K
- Jazz Pharmaceuticals Inc.$1K
- Axsome Therapeutics, Inc.$600
- Biohaven Pharmaceutical Holding Company Ltd.$504
- Philips North America LLC$440
- plus $2K from 17 others
Across 19 payments — averaging $4581.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Harmony Biosciences LLC$87K
What the payments were for
- Consulting fees$1,0485%
- Speaking & faculty fees$8,44242%
- Travel & lodging$4,11521%
- Food & beverage$6,10631%
- Education$1621%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Harmony Biosciences LLC | 58 | $11,715 |
| Inspire Medical Systems, Inc. | 28 | $3,506 |
| Jazz Pharmaceuticals Inc. | 53 | $1,470 |
| Axsome Therapeutics, Inc. | 19 | $600 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $504 |
| Philips North America LLC | 18 | $440 |
| 3b Medical, Inc. | 6 | $298 |
| Merck | 12 | $214 |
| GSK | 8 | $205 |
| Resmed Corp | 8 | $154 |
| United Therapeutics Corporation | 1 | $148 |
| Fisher & Paykel Healthcare Inc | 5 | $142 |
| ZOLL Respicardia, Inc. | 2 | $87 |
| Eisai Inc. | 4 | $68 |
| Arbor Pharmaceuticals, Inc. | 4 | $67 |
| Aytu Biopharma, Inc. | 3 | $56 |
| Insmed, Inc. | 2 | $45 |
| Lilly USA, LLC | 2 | $39 |
| Boehringer Ingelheim | 1 | $30 |
| Idorsia Pharmaceuticals US Inc | 2 | $30 |
| Azurity Pharmaceuticals, Inc. | 1 | $22 |
| UCB, Inc. | 1 | $19 |
| AstraZeneca | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wakix$10,935
- Inspire Upper Airway Stimulation System$3,076
- NURTEC ODT$301
- SUNOSI$230
- LUNA$166
- TYVASO$148
- XYWAV$120
- XYREM$105
- TRELEGY ELLIPTA$104
How this compares
$19,872 in reported general payments places this provider in the 90th percentile of 50 sleep medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| WakixPitolisant Hcl | 63 | $883,571 |
| Ramelteon | 11 | $1,587 |
| Hydroxyzine Hcl | 27 | $722 |
| Trazodone Hcl | 74 | $469 |
| Ropinirole Hcl | 21 | $286 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 20 | $191 |
| Doxepin Hcl | 11 | $160 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Harmony Biosciences LLCWakix | $11,715 | $883,57163 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 50 sleep medicine providers in Georgia.
Other sleep medicine in Trenton
- Murad AssaadAtlanta$139K
- Nancy CollopAtlanta$28K
- Scott LeibowitzAtlanta$22K
- Chantale BransonAtlanta$17K
- Melissa RhodesCartersville$14K
- James DalySavannah$12K
- Romy HoqueAtlanta$10K
- Naseer HumayunDalton$7K
- Praveen RastogiStockbridge$7K
- Avery NathansonDecatur$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.